282 related articles for article (PubMed ID: 30759233)
1. Massive Ovarian Growth in a Woman With Severe Insulin-Resistant Polycystic Ovary Syndrome Receiving GnRH Analogue.
Singh P; Agress A; Madrigal VK; Magyar C; Ostrzega N; Chazenbalk GD; Dumesic DA
J Clin Endocrinol Metab; 2019 Jul; 104(7):2796-2800. PubMed ID: 30759233
[TBL] [Abstract][Full Text] [Related]
2. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
[TBL] [Abstract][Full Text] [Related]
3. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.
Foong SC; Abbott DH; Zschunke MA; Lesnick TG; Phy JL; Dumesic DA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance.
Huang-Doran I; Kinzer AB; Jimenez-Linan M; Thackray K; Harris J; Adams CL; de Kerdanet M; Stears A; O'Rahilly S; Savage DB; Gorden P; Brown RJ; Semple RK
J Clin Endocrinol Metab; 2021 Jul; 106(8):2367-2383. PubMed ID: 33901270
[TBL] [Abstract][Full Text] [Related]
5. Insulin and hyperandrogenism in women with polycystic ovary syndrome.
Baptiste CG; Battista MC; Trottier A; Baillargeon JP
J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):42-52. PubMed ID: 20036327
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
[TBL] [Abstract][Full Text] [Related]
7. Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.
Garmes HM; Tambascia MA; Zantut-Wittmann DE
Gynecol Endocrinol; 2005 Dec; 21(6):317-23. PubMed ID: 16390779
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
Baskind NE; Balen AH
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
10. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
Siddiqui S; Mateen S; Ahmad R; Moin S
J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunocytologic localization of insulin-like growth factor binding protein-4 in normal and polycystic ovary syndrome human ovaries.
Peng X; Maruo T; Samoto T; Mochizuki M
Endocr J; 1996 Jun; 43(3):269-78. PubMed ID: 8886620
[TBL] [Abstract][Full Text] [Related]
12. Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
Chang PL; Lindheim SR; Lowre C; Ferin M; Gonzalez F; Berglund L; Carmina E; Sauer MV; Lobo RA
J Clin Endocrinol Metab; 2000 Mar; 85(3):995-1000. PubMed ID: 10720029
[TBL] [Abstract][Full Text] [Related]
13. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
[TBL] [Abstract][Full Text] [Related]
14. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
15. [Should infertile women with polycystic ovarian syndrome be treated with metformine?].
Massin N; Galey J; Basille C; Théron-Gérard L; Bry-Gauillard H; Cédrin-Durnerin I; Hugues JN
Gynecol Obstet Fertil; 2003 Mar; 31(3):265-74. PubMed ID: 12770812
[TBL] [Abstract][Full Text] [Related]
16. A case report of ovarian granulosa cell tumor in patient with polycystic ovarian syndrome.
Kim YS; Lee JH
Medicine (Baltimore); 2021 Dec; 100(50):e28261. PubMed ID: 34918698
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome.
Hong SH; Sung YA; Hong YS; Jeong K; Chung H; Lee H
Clin Endocrinol (Oxf); 2017 Oct; 87(4):375-380. PubMed ID: 28543550
[TBL] [Abstract][Full Text] [Related]
18. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
19. MORE THAN MEETS THE EYE IN A PATIENT WITH PCOS: ANDROGEN-SECRETING GRANULOSA CELL OVARIAN TUMOR IN A VIRILIZED WOMAN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS).
Harris AA; Kabadi UM
AACE Clin Case Rep; 2020; 6(4):e170-e173. PubMed ID: 32734001
[TBL] [Abstract][Full Text] [Related]
20. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
Jonard S; Dewailly D
Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
